Table 2 The results of tumor markers evaluation
From: Selecting treatment method for ovarian masses in children – 24 years of experience
Histological type | |||||
|---|---|---|---|---|---|
Tumor-like lesion | Benign tumor | Malignant tumor | Summary | ||
marker | AFP | 0 | 1 | 5 | 6 |
β-hCG | 0 | 0 | 4 | 4 | |
CA125 | 7 | 4 | 5 | 16 | |
LDH | 1 | 1 | 6 | 8 | |
Large Lesion and Positive Markers* | 1/57 (1.75%) | 6/45 (13.33%) | 12/20 (60.00%) | 15.57% | |
* (among patients with markers tested) | |||||
Solid Lesion and Positive Markers | 1/56 (1.78%) | 0/45 (0%) | 5/18 (27.78%) | 5.04% | |
*(among patients with markers tested and US performed) | |||||